Skip to main content
. 2015 Nov 25;10(11):e0143803. doi: 10.1371/journal.pone.0143803

Fig 1. Area map of Greece according to WNV IgG seroprevalence levels (level NUTS 3) together with the geographical distribution of recorded human cases recorded during 2010–2012.

Fig 1